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Background: Movement disorders after stroke are still captured by clinical gaze and translated to ordinal scores of
low resolution. There is a clear need for objective quantification, with outcome measures related to
pathophysiological background. Neural and non-neural contributors to joint behavior should be separated using
different measurement conditions (tasks) and standardized input signals (force, position and velocity).
Methods: We reviewed recent literature for the application of biomechanical and/or elektromyographical (EMG)
outcome measures under various measurement conditions in clinical research.
Results: Since 2005, 36 articles described the use of biomechanical and/or EMG outcome measures to quantify
post-stroke movement disorder. Nineteen of the articles strived to separate neural and non-neural components.
Only 6 of the articles measured biomechanical and EMG outcome measures simultaneously, while applying active
and passive tasks and multiple velocities.
Conclusion: The distinction between neural and non-neural components to separately assess paresis, stiffness and
muscle overactivity is not commonplace yet, while a large gap is to be bridged to attain reproducible and
comparable results. Pathophysiologically clear concepts, substantiated with a comprehensive and concise
measuring protocol will help professionals to identify and treat limiting factors in movement capabilities of post-
stroke patients.
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Introduction
Movement disorders after stroke are the result of a com-
plex interaction of primary neural damage and second-
ary tendomuscular changes [1,2]. The combination of
paresis, stiffness and muscle overactivity leads to a
phenotype that is easy to recognize clinically, but hard
to quantify [1]. The broadly used term “spasticity” is
under debate. Different definitions are used, and while it
is mostly used as an umbrella-term for the phenotype, it
describes only a part of the movement disorder [3-7],
and has little relation to the capabilities of a patient to
perform under different circumstances.
Clinical gaze and manual tests to assess movement
disorder after stroke are readily available to every phys-
ician and are currently used as a basis for clinical* Correspondence: j.m.van_der_krogt@lumc.nl; c.g.m.meskers@lumc.nl
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distribution, and reproduction in any mediumpractice. However, there are some difficulties in evaluat-
ing interventions within patients and between studies.
For example, resolution of clinical tests is low, rater de-
pendency is variable and conditions are difficult to
standardize [8,9]. Little is known about responsiveness
of the clinical tests to change. Ordinal scales are often
misused as linear entities. Also, the measured construct
of tests is not always taken into account when choosing
a test for the assessment of stroke patients [9], i.e. im-
provement in tests on the domains of body structures
and functions of the International Classification of Func-
tioning, Disability and Health (ICF) do not automatically
lead to improvement in the domains of activities and
participation.
Correct use of a meaningful pathophysiological con-
struct will enable clinicians to target their expensive and
labor intensive therapies such as botulinum toxin and
exercise programs more efficiently and effectively. Evi-
dently, this challenges the community of rehabilitation
specialists to quantify and objectify the components ofentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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logical origin [10,11] and their relevance for perform-
ance in the different ICF domains. For the domain of
Body Structures and Body Functions this means that,
first of all, input signals (e.g. velocity, force, angle)
should be standardized to enable comparability and re-
peatability. Second, multiple measuring conditions
should be applied to trigger the different pathophysio-
logical components [10,11], i.e. active tasks to study vol-
untary muscle properties, passive tasks to study passive
tissue properties, and multiple measurement velocities
to elicit stretch reflexive behavior. This will allow for dif-
ferentiation in neural and non-neural components (see
Table 1), and will enable clinicians to direct their therap-
ies more precisely. Simultaneously used biomechanical
and electrophysiological techniques can support the
identification of active, passive and reflexive components
and their complex (non linear) interactions.
Recommendations for objective and quantitative as-
sessment of movement disorders after stroke are readily
available [6,9,12,13]. However, it is unclear to which ex-
tent these recommendations are implemented in
current research and clinical practice. The aim of the
present paper is to provide an overview of biomechan-
ical and electrophysiological outcome measures recently
used to describe post-stroke movement disorders. In
addition, the use of underlying pathophysiological con-
structs is investigated.
Methods
We conducted a literature search on PubMed and Web
of Science with the following search terms: PubMed:
stroke AND biomechanics AND electromyography (lim-
its: last 5 year, human, adult)(accessed dec 2010). Web
of Science: TS = ((stroke AND outcome measures) AND
(biomechanic OR electromyography)). We also tracked
references and citations. Thereafter we checked for dou-
bles and scanned titles and abstracts. For a flow chart of
the search, see Figure 1.
Within the found references, we identified biomechan-
ical and electromyographical (EMG) outcome measures,
used in research on stroke patients. We searched for theTable 1 Division of components of post stroke movement
disorder in non-neural and neural properties offers a




Non-neural Passive Stiffness, changed properties
of connective tissue and joints





reflex behaviorpathophysiological construct of these outcome measures,
given by the authors. Biomechanical and EMG outcome
measures were examined for task instruction (active or
passive) and for applied velocities of perturbations (slow,
fast or multiple velocities). Subsequently, the outcome
measures were separated in clusters, according to the
applied method. For biomechanical outcome measures,
the clusters were: range of motion, stiffness (or resist-
ance to passive movement), maximum voluntary con-
traction, viscosity, work, mathematical models, other.
For EMG outcome measures, the clusters were: magni-
tude, threshold (angle), onset (time), co-activation, other.Results
The search yielded 37 articles. A flowchart of the search
is illustrated in Figure 1. Study characteristics (measured
segment, number of subjects, category of research) and
the biomechanical and electrophysiological outcome
measures found in each article, are summarized in
Additional file 1: Table S1.
Of the 37 articles, 3 were review articles [14-16].
In the other 34 articles, 30 included EMG outcome
measures [17-45] and 31 included biomechanical
outcome measures, while 25 articles included both.
Active and passive tasks were found in 10 articles
[17,19,20,26,27,29,33,34,38,46]. Different measuring vel-
ocities were found in 19 articles [18-22,24,27,30-35,37-
39,43,44,47]. In 6 articles, all of the aforementioned
properties were present (see Figure 2) [19,20,27,33,34,38].
In 6 articles the biomechanical and/or EMG were used
to evaluate treatment of stroke patients [17,26,28,31,37,43],
10 articles addressed reliability or feasibility of the outcome
measures in stroke patients [20,21,23,32,35,44,45,47-49]
and 18 articles were observational (difference between
healthy subjects and stroke patients) or tested a new
measuring method [18,19,22,24,25,27,29,30,33,34,36,38-
42,46,50]. A total of 682 stroke patients and 175
healthy subjects were included (see Additional file 1:
Table S1).
In 25 articles the biomechanical and EMG techniques
were used to objectify or quantify a clinical concept (e.g.
spasticity, muscle tone, muscle activity, impairment or
coupling) [18,20,22-27,29-33,35,37,39-47,50]. Alongside
this, a large part of the articles use these techniques to
separate the underlying (neural and non-neural)
mechanisms of the concept (n = 19) [18-24,30,31,33-
35,37,39,40,42-45]. Finally, there is also a small number
of articles that advocate standardized input (n = 6) [19-
21,24,30,40].Biomechanical outcome measures
An overview of biomechanical outcome measures is pre-
sented in Additional file 1: Table S1.
PubMed search: 
47
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- 35 
Citations and references: 
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Figure 1 A flow chart of the search strategy and outcome.
van der Krogt et al. Journal of NeuroEngineering and Rehabilitation 2012, 9:61 Page 3 of 7
http://www.jneuroengrehab.com/content/9/1/61Range of motion was assessed as passive range of mo-
tion (pain-free or comfortable range of movement about
a joint) (n = 12), active range of motion (n = 3) or both
(n = 3). An electrogoniometer was used in 7 articles
[17,18,22,25,35,46-48], customized devices were used in
8 articles [19,20,32,34,38,44,45,49] and in 2 articles man-








Passive & active tasks:  
10 articles 04
612
Figure 2 Number of articles conforming to recommendations
for measuring movement disorder after stroke: measuring
active and passive tasks, measuring at multiple velocities and
including EMG-techniques.Maximum voluntary contraction was measured with
a handheld dynamometer (n = 1) [17], or a torque
transducer/load cell in a (customized) device (n = 11)
[19,27-29,33,34,36,38,39,41,49]. Isometric conditions
were applied in 11 articles, while in 1 article the peak
active torque during flexion/extension movement was
measured [19].
Stiffness or resistance to passive movement was mea-
sured as force or torque versus angle during passive
movement, with the identical device as used for max-
imum voluntary contraction. The methods ranged from
measuring peak resistance during movement (n = 2)
[30,48], calculating the slope of the force-angle curve,
linearized over a part [19,20,22,23,32,43] or the total
[24,30,32,35,43] of the movement trajectory (n = 10), to a
model fit (n = 5) [33,34,38,44,45]. A minority compared
stiffness at different velocities (n = 5) [24,30,32,35,43].
Viscosity (n = 3) was derived from force and position
at different velocities during passive movement
[29,31,37]. Work (n = 2) was calculated as the area under
the curve of moment-angle, during passive movement
[18,30]. Mathematical models (n = 3) were used to com-
pare the estimated or predicted parameter with the ac-
tual parameter. This was done once for muscle length
[27], once for torque [33] and once for angle trajectory
[42].
Other biomechanical parameters assessed (n = 25)
were tracking index (correlation between target angle
and actual angle) [19,20], relaxation index (difference in
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test) [25], velocity dependent torque [18,33-35,44,45],
phase dependent torque (timing of joint resistance com-
pared to movement) [29,37], movement pattern (range
of motion related to duration of phase) [46], miscellan-
eous other torque parameters [18,23,30,38,40,50] and
gains [44,45]. Most attempted to cipher some spasticity
parameter, using different combinations of velocities or
positions and resulting torque.Electrophysiological outcome measures
All electrophysiological outcome measures were mea-
sured using surface electromyography (EMG). An over-
view of EMG outcome measures is presented in
Additional file 1: Table S1.
Magnitude of EMG signal was measured during max-
imum voluntary contraction (isometric) (n = 5)
[27,28,33,39,41], with a target force or target EMG-level
(n = 2) [27,39], during passive movement (n = 18) [17-
20,22-26,30,33,36,38,40,43,44,46] or during active move-
ment [46]. Tendon taps were used in 2 articles [23,40]
and H-reflex stimulation was used in 2 articles [26,36].
In all cases the EMG was rectified and/or normalized.
The EMG activity during maximum voluntary contrac-
tion was mostly used as a reference value for the magni-
tude of reflex EMG response. In 6 cases, EMG activation
was compared between different velocities or task
instructions [22,30,35,39,43,46].
Threshold was described as the angle at which EMG
activity started during passive movement. Thresholds
were compared between different velocities of perturb-
ation [21,30,31,37]. Onset was described as the latency
in time between start of perturbation and start of EMG





Spasticity 16 3 2
Muscle tone or hypertonia 5 0 0
Muscle overactivity 4* 0 1
Other
- paresis 1 1 0
- motor control 1 0 0
- impairment 2 2 2
- coupling 3# 0 0
- secondary changes 1 1 0
- normalization 1 0 0
*muscle overactivity (n = 2), reflex response (n = 2); # affected & non affected side (n
(n = 1).Co-activation (or cocontraction) compared agonistic
and antagonistic EMG-activity during passive movement
(n = 4) [19,20,44,45], during active movement (n = 1) [46]
or maximum voluntary contraction (n = 1) [34].
Other parameters of EMG (n = 9) that were assessed,
include velocity dependent EMG signal [35], tonic
threshold (extrapolation of thresholds from different vel-
ocities to zero velocity) [21], duration of activity [29],
modulation of activity [29], volitional response time
[27,39], slope of recruitment curve and H-reflex related
parameters [36].Pathophysiological construct of outcome measures
Observed pathophysiological constructs were spasticity
(n = 16) [17,21-26,32,33,35,37,44-48], muscle tone
[18,30,31,42,43], muscle overactivity [28,39,40,50], par-
esis [49], motor control [29], impairment [19,20], coup-
ling between extremities [27,36,38], secondary changes
[34] and normalization of signals [41]. Observed under-
lying mechanisms used to underpin the pathophysio-
logical constructs were paresis [17,19-21,24,34,49],
limited range of motion [19,20,46,50], stiffness/hyper-
tonia [18-25,30-35,37,38,42-45,47,50], muscle overactiv-
ity/hyperreflexia [17,20-25,27-31,34-40,43,45,50] and
motor control/dexterity [19,20,29,33,46,49]. An overview
of the cross-links between observed pathophysiological
constructs and underlying mechanisms is presented in
Table 2.
The most addressed concept was that of spasticity
(n = 16), although different definitions and interpreta-
tions were given [17,21-26,32,33,35,37,44-48]. The
observed underlying mechanism was in either non-
neural (stiffness, resistance) (n = 4) [32,33,45,47], neural



















= 1), upper & lower extremity (n = 1), proximal & distal segment of extremity
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cles concerning the concept of spasticity did not dis-
criminate between neural and non-neural components
(n = 2) [26,48].
The second most addressed concept was that of
muscle tone (n = 5) [18,30,31,42,43]. All five use non-
neural components of muscle tone as underlying mech-
anism (i.e. stiffness, inertia, mechanical characteristics of
passive tendomuscular and connective tissue, mechan-
ical characteristics of activated muscle), while neural
components (muscle overactivity, hyperreflexia) were
separately addressed in 3 articles [30,31,43].
The concept of muscle overactivity was the main topic
in 4 articles [28,39,40,50]. Two articles distinguish be-
tween neural and non-neural properties (n = 2) [39,40].
The underlying mechanisms of stiffness and muscle
overactivity were combined in 15 out of the 37 articles
[19,21-25,30,31,34,35,37,38,40,43,45].Discussion
Since 2005, 37 articles described the use of biomechan-
ical and/or EMG outcome measures to describe post-
stroke movement disorder. Nineteen of the articles
strived to separate neural from non-neural components.
The most frequent pathophysiological constructs were
spasticity, muscle tone and muscle overactivity. Only 6
of the articles measure biomechanical and EMG out-
come measures simultaneously, while applying active
and passive tasks and multiple velocities.
Whilst this study limited the use of search engines to
PubMed and Web of Science, it is likely that the main
bulk of relevant literature is identified by using generic
search terms and cross-checking references. The restric-
tion to search only recent literature is justified by the
specific aim of the study, namely, to identify current
methods.
This review shows that in recent years initiatives have
been taken to quantify and objectify measurements in
post stroke movement disorders. It also indicates that
the conceptual mainframe of separating movement dis-
order into neural and non-neural components was not
always taken into account, i.e. active, passive and reflex
contributions were not always divided. In some articles,
there was a lack of consistency in administration of the
underlying pathophysiological mechanism (paresis,
increased stiffness and muscle overactivity) or patho-
physiological concept (spasticity, muscle tone). For ex-
ample: one [50] of the 4 papers on muscle overactivity
did not use EMG. Another example is spasticity, which
was described as velocity dependent in 13 of the 16
papers [17,21,23-26,32,33,35,44,45,47,48], while only 8 of
the 16 papers use multiple velocities in their tests
[21,22,24,32,33,35,37,47].Measuring in different operating points is not com-
monplace yet, while it will allow for a more complete
understanding of the capabilities of a patient with a
movement disorder. Active and passive tasks instruc-
tions will give information about paresis and involun-
tary muscle activity, and a variation of velocities of
perturbations will illuminate stiffness and reflex contri-
butions. A more specific knowledge of the capabilities
of a patient will probably lead to a more specific treat-
ment. For example, patients with movement disorder
due to severe paresis or reduced range of motion
through secondary changes will not benefit from spas-
molytic or neurolytic treatment. However, before treat-
ment in spastic patients, these disorders are not
systematically separated from muscle overactivity. This
does not benefit the individual patient, is not cost
effective and will introduce a bias in research of effect
measurements after treatment.
The techniques as described in this review are mostly
not available in clinical practice yet. This has led to
prolonged use of clinical scores, despite their known
disadvantages. We recommend that future work on
movement disorder in stroke patients should be based
on a clear concept and include a comprehensive and
concise measurement protocol which is easily applied
on and well tolerated by stroke patients. Outcome mea-
sures should be pathophysiologically meaningful and
applicable in decision making for clinicians. Addition-
ally, to increase the understanding of primary and sec-
ondary changes, longitudinal studies will be essential
[51]. This will enable specialists in physical medicine
and rehabilitation to tailor their therapies and, more-
over, allow them to assess the effect of (experimental)
interventions.
Conclusion
In the last 6 years a number of initiatives were developed
to quantify and objectify movement disorder after stroke.
However, the distinction between non-neural and neural
components to separately assess paresis, stiffness and
muscle overactivity, is not commonplace yet. A large gap
has to be bridged to attain reproducible and comparable
results.
Pathophysiologically clear concepts, substantiated with
a comprehensive and concise measuring protocol will
help professionals to identify and treat limiting factors in
movement capabilities of post-stroke patients.
Additional file
Additional file 1: Table S1. Study characteristics (measured
segment, number of subjects, category of research) and the
biomechanical and electrophysiological outcome measures found in
each article.
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